PDB Short entry for 1Q4V HEADER HORMONE/GROWTH FACTOR 04-AUG-03 1Q4V TITLE CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRAL ANALOGUE: TITLE 2 IMPLICATIONS FOR THE MECHANISM OF RECEPTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: INSULIN A CHAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INSULIN; COMPND 8 CHAIN: B, D; COMPND 9 FRAGMENT: INSULIN B CHAIN; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PROTEIN WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 4 OF THE PROTEIN IS NATURALLY FOUND IN HOMO SAPIENS (HUMAN).; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 OTHER_DETAILS: THE PROTEIN WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 8 OF THE PROTEIN IS NATURALLY FOUND IN HOMO SAPIENS (HUMAN). KEYWDS ALLO-ILE-A2-INSULIN, PROTEIN UNFOLDING, INSULIN RECEPTOR, HORMONE- KEYWDS 2 GROWTH FACTOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.L.WAN,B.XU,Y.C.CHU,P.G.KATSOYANNIS,M.A.WEISS REVDAT 5 16-AUG-23 1Q4V 1 REMARK SEQADV LINK REVDAT 4 13-JUL-11 1Q4V 1 VERSN REVDAT 3 24-FEB-09 1Q4V 1 VERSN REVDAT 2 18-NOV-03 1Q4V 1 JRNL ATOM REVDAT 1 19-AUG-03 1Q4V 0 SPRSDE 19-AUG-03 1Q4V 1PC1 JRNL AUTH Z.L.WAN,B.XU,Y.C.CHU,P.G.KATSOYANNIS,M.A.WEISS JRNL TITL CRYSTAL STRUCTURE OF ALLO-ILE(A2)-INSULIN, AN INACTIVE JRNL TITL 2 CHIRAL ANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR JRNL TITL 3 BINDING. JRNL REF BIOCHEMISTRY V. 42 12770 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 14596591 JRNL DOI 10.1021/BI034430O REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.XU,Q.X.HUA,S.H.NAKAGAWA,W.JIA,Y.C.CHU,P.G.KASOYANNIS, REMARK 1 AUTH 2 M.A.WEISS REMARK 1 TITL CHIRAL MUTAGENESIS OF INSULIN'S HIDDEN RECEPTOR-BINDING REMARK 1 TITL 2 SURFACE: STRUCTURE OF AN ALLO-ISOLEUCINE (A2) ANALOGUE REMARK 1 REF J.MOL.BIOL. V. 316 435 2002 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.2001.5377 REMARK 1 REFERENCE 2 REMARK 1 AUTH B.XU,Q.X.HUA,S.H.NAKAGAWA,W.JIA,Y.C.CHU,P.G.KATSOYANNIS, REMARK 1 AUTH 2 M.A.WEISS REMARK 1 TITL A CAVITY-FORMING MUTATION IN INSULIN INDUCES SEGMENTAL REMARK 1 TITL 2 UNFOLDING OF A SURROUNDING ALPHA-HELIX REMARK 1 REF PROTEIN SCI. V. 11 104 2002 REMARK 1 REFN ISSN 0961-8368 REMARK 1 DOI 10.1110/PS.PS.32102 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.A.WEISS,Z.WAN,M.ZHAO,Y.C.CHU,S.H.NAKAGAWA,G.T.BURKE,W.JIA, REMARK 1 AUTH 2 R.HELLMICH,P.G.KATSOYANNIS REMARK 1 TITL NON-STANDARD INSULIN DESIGN: STRUCTURE-ACTIVITY REMARK 1 TITL 2 RELATIONSHIPS AT THE PERIPHERY OF THE INSULIN RECEPTOR REMARK 1 REF J.MOL.BIOL. V. 315 103 2002 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.2001.5224 REMARK 1 REFERENCE 4 REMARK 1 AUTH R.L.BALDWIN,G.D.ROSE REMARK 1 TITL IS PROTEIN FOLDING HIERARCHIC? I. LOCAL STRUCTURE AND REMARK 1 TITL 2 PEPTIDE FOLDING REMARK 1 REF TRENDS BIOCHEM.SCI. V. 24 26 1999 REMARK 1 REFN ISSN 0968-0004 REMARK 1 DOI 10.1016/S0968-0004(98)01346-2 REMARK 1 REFERENCE 5 REMARK 1 AUTH R.L.BALDWIN,G.D.ROSE REMARK 1 TITL IS PROTEIN FOLDING HIERARCHIC? II. FOLDING INTERMEDIATES AND REMARK 1 TITL 2 TRANSITION STATES REMARK 1 REF TRENDS BIOCHEM.SCI. V. 24 77 1999 REMARK 1 REFN ISSN 0968-0004 REMARK 1 DOI 10.1016/S0968-0004(98)01345-0 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 5892 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.400 REMARK 3 FREE R VALUE TEST SET COUNT : 613 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 753 REMARK 3 BIN R VALUE (WORKING SET) : 0.3310 REMARK 3 BIN FREE R VALUE : 0.3780 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 89 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 810 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 9 REMARK 3 SOLVENT ATOMS : 64 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.18000 REMARK 3 B22 (A**2) : -2.18000 REMARK 3 B33 (A**2) : 6.82000 REMARK 3 B12 (A**2) : 2.43000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.24 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.25 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 2.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.900 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.410 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.050 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.470 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.100 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.29 REMARK 3 BSOL : 37.66 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Q4V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-AUG-03. REMARK 100 THE DEPOSITION ID IS D_1000019918. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-NOV-01 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5897 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 23.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 2.070 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 43.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.30100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1TRZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TRIS, SODIUM CITRATE, ACETONE, PHENOL, REMARK 280 PH 6.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.24350 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.23460 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 12.64633 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 40.24350 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 23.23460 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 12.64633 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 40.24350 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 23.23460 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 12.64633 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 46.46919 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 25.29267 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 46.46919 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 25.29267 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 46.46919 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 25.29267 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE CRYSTALLOGRAPHIC ASYMMETRY UNIT OF INSULIN CONSISTS OF REMARK 300 TWO MONOMERS EACH CONSISTING TWO HETEROCHAINS. THE ENTRY PRESENTS REMARK 300 COORDINATES FOR MONOMER 1 (CHAIN INDICATORS A AND B)AND MONOMER 2 REMARK 300 (CHAIN INDICATORS C AND D). THERE ARE TWO ZINC IONS PER INSULIN REMARK 300 HEXAMER LOCATED ON THE THREE-FOLD AXIS. THE CONFORMATIONS OF TWO REMARK 300 MONOMERS ARE DIFFERENT THE RESULT OF B CHANGED IN CONFORMATION OF REMARK 300 THE FIRST RESIDUES OF THE B-CHAIN. THE BIOLOGICAL ASSEMBLY IS A REMARK 300 HEXAMER GENERATED FROM THE DIMER IN THE ASYMMETRIC UNIT BY THE REMARK 300 OPERATIONS: -Y,X-Y,Z AND -X+Y,-X,Z REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10190 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -100.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 40.24350 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 69.70379 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -40.24350 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 69.70379 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -105.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 40.24350 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 69.70379 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -40.24350 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 69.70379 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DODECAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 18730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -255.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 40.24350 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 69.70379 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -40.24350 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 69.70379 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 ZN ZN B 101 LIES ON A SPECIAL POSITION. REMARK 375 ZN ZN D 102 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN D 3 93.86 -57.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 101 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 10 NE2 REMARK 620 2 HIS B 10 NE2 114.9 REMARK 620 3 HIS B 10 NE2 114.7 115.0 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN D 102 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 10 NE2 REMARK 620 2 HIS D 10 NE2 87.7 REMARK 620 3 HIS D 10 NE2 87.8 87.8 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN D 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH C 200 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TRZ RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC EVIDENCE FOR DUAL COORDINATION AROUND ZINC IN THE REMARK 900 T3R3 HUMAN INSULIN HEXAMER. DBREF 1Q4V A 1 21 GB AAA59172 AAA59172 90 110 DBREF 1Q4V C 1 21 GB AAA59172 AAA59172 90 110 DBREF 1Q4V B 1 30 GB AAA59172 AAA59172 25 54 DBREF 1Q4V D 1 30 GB AAA59172 AAA59172 25 54 SEQADV 1Q4V IIL A 2 GB AAA59172 ILE 91 MODIFIED RESIDUE SEQADV 1Q4V IIL C 2 GB AAA59172 ILE 91 MODIFIED RESIDUE SEQRES 1 A 21 GLY IIL VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 B 30 THR PRO LYS THR SEQRES 1 C 21 GLY IIL VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 C 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 D 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 D 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 D 30 THR PRO LYS THR MODRES 1Q4V IIL A 2 ILE ISO-ISOLEUCINE MODRES 1Q4V IIL C 2 ILE ISO-ISOLEUCINE HET IIL A 2 8 HET IIL C 2 8 HET ZN B 101 1 HET IPH C 200 7 HET ZN D 102 1 HETNAM IIL ISO-ISOLEUCINE HETNAM ZN ZINC ION HETNAM IPH PHENOL HETSYN IIL ALLO-ISOLEUCINE FORMUL 1 IIL 2(C6 H13 N O2) FORMUL 5 ZN 2(ZN 2+) FORMUL 6 IPH C6 H6 O FORMUL 8 HOH *64(H2 O) HELIX 1 1 GLY A 1 CYS A 7 1 7 HELIX 2 2 LEU A 16 CYS A 20 5 5 HELIX 3 3 GLY B 8 GLY B 20 1 13 HELIX 4 4 GLY C 1 CYS C 6 1 6 HELIX 5 5 SER C 12 GLU C 17 1 6 HELIX 6 6 ASN C 18 CYS C 20 5 3 HELIX 7 7 ASN D 3 GLY D 20 1 18 SHEET 1 A 2 PHE B 25 TYR B 26 0 SHEET 2 A 2 PHE D 24 PHE D 25 -1 O PHE D 24 N TYR B 26 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.02 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.03 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.03 SSBOND 4 CYS C 6 CYS C 11 1555 1555 2.01 SSBOND 5 CYS C 7 CYS D 7 1555 1555 2.02 SSBOND 6 CYS C 20 CYS D 19 1555 1555 2.03 LINK C GLY A 1 N IIL A 2 1555 1555 1.33 LINK C IIL A 2 N VAL A 3 1555 1555 1.34 LINK C GLY C 1 N IIL C 2 1555 1555 1.34 LINK C IIL C 2 N VAL C 3 1555 1555 1.34 LINK NE2 HIS B 10 ZN ZN B 101 1555 1555 1.99 LINK NE2 HIS B 10 ZN ZN B 101 2665 1555 1.99 LINK NE2 HIS B 10 ZN ZN B 101 3565 1555 1.99 LINK NE2 HIS D 10 ZN ZN D 102 1555 1555 2.08 LINK NE2 HIS D 10 ZN ZN D 102 2665 1555 2.08 LINK NE2 HIS D 10 ZN ZN D 102 3565 1555 2.07 SITE 1 AC1 1 HIS B 10 SITE 1 AC2 1 HIS D 10 SITE 1 AC3 5 LEU B 17 CYS C 6 ILE C 10 CYS C 11 SITE 2 AC3 5 ALA D 14 CRYST1 80.487 80.487 37.939 90.00 90.00 120.00 H 3 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012424 0.007173 0.000000 0.00000 SCALE2 0.000000 0.014346 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026358 0.00000